CD47 and breast carcinoma: Further support that metformin can target breast cancer stem cells (BCSCs) came from a study of Tan et al., where metformin treatment of MCF-7.SC and MDA-MB-231.SC resulted in increased expression of miR-708 and decreased expression of CD47 mRNA in both cell lines.